Persistent Oral Human Papillomavirus (HPV) Infection is Associated with Low Salivary Levels of Matrix Metalloproteinase 8 (MMP-8). 2017

Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
Department of Oral Pathology and Oral Radiology, Institute of Dentistry and MediCity Research Laboratory, University of Turku, Turku, Finland. Electronic address: anna.haukioja@utu.fi.

A persistent human papillomavirus (HPV) infection is a prerequisite for a HPV related cancer to develop. Asymptomatic, persistent HPV infections are not only found in genital tract, but also on oral mucosa. Oral HPV persistence may be associated with behavioural factors, but data on the role of innate immunity in oral HPV infections are still limited. Salivary concentrations of matrix metalloproteinases MMP-8 and MMP-9, tissue inhibitor of MMPs (TIMP-1), myeloperoxidase, and serum concentrations of MMP-8 were analysed in women with a persistent oral HPV infection and, as a control, in women who remained HPV DNA-negative during a 6-year follow-up. The effects of smoking, lactation and alcohol use on the salivary and serum parameters were assessed, too. A nested case-control setting was used to select a subgroup of 57 women with a persistent oral HPV infection and 102 controls from the Finnish Family HPV Study. The salivary MMP-8/TIMP-1 molar ratio was lower in HPV DNA-positive women than in controls (p=0.036). The difference was more pronounced in non-smoking women, in this group also the salivary MMP-8 levels differed (p=0.047). There was a correlation between the salivary concentrations of myeloperoxidase and MMP-8 (r=0.567, p<0.001) or MMP-9 (r=0.234, p=003), but no correlation between salivary and serum MMP-8 levels. The MMP-9 concentration and the MMP-9/TIMP-1 molar ratio were significantly lower in smokers than in non-smokers (p=0.020 and p=0.003, respectively). Persistent oral HPV infection was associated with a low salivary MMP-8 concentration indicating eventually a failure in oral anti-inflammatory defence.

UI MeSH Term Description Entries
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074285 Smokers Persons with a history or habit of SMOKING. Smokers, Non-Tobacco Products,Smokers, Tobacco,Vapers,Non-Tobacco Products Smoker,Non-Tobacco Products Smokers,Smoker,Smoker, Non-Tobacco Products,Smoker, Tobacco,Smokers, Non Tobacco Products,Tobacco Smoker,Tobacco Smokers,Vaper
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D019715 Tissue Inhibitor of Metalloproteinase-1 A member of the family of TISSUE INHIBITOR OF METALLOPROTEINASES. It is a N-glycosylated protein, molecular weight 28 kD, produced by a vast range of cell types and found in a variety of tissues and body fluids. It has been shown to suppress metastasis and inhibit tumor invasion in vitro. TIMP-1,Metalloproteinase-1 Tissue Inhibitor,Tissue Inhibitor of Metalloproteinase 1

Related Publications

Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
September 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
October 2000, Journal of periodontal research,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
March 2015, Frontiers of medicine,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
February 2007, Archives of oral biology,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
January 2006, Experimental dermatology,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
January 2015, Caries research,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
September 2006, Medicinal chemistry (Shariqah (United Arab Emirates)),
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
November 2025, Caries research,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
June 2024, The oncologist,
Anna Haukioja, and Taina Tervahartiala, and Timo Sorsa, and Stina Syrjänen
January 2010, Acta oncologica (Stockholm, Sweden),
Copied contents to your clipboard!